EPISODE · Jan 5, 2026 · 32 MIN
346:The 2026 MedTech Exit Playbook: How Spin-Outs Like DePuy Synthes Are Changing M&A Forever.
from State of Medtech · host State of Medtech
In this episode Omar Khateeb, Founder of MarketCraft, breaks down the biggest trend reshaping MedTech in 2026: the explosion of "Mini-Strategics." These multi-billion dollar, pure-play spin-outs from giants like J&J and 3M are becoming focused acquirers, finally addressing the industry's chronic exit and liquidity problem. Omar explains how this creates a virtuous cycle, unlocking capital for earlier-stage risk and bolder innovation. He then provides founders with a concrete, 5-step playbook to build leverage, engineer their market category, and position their company as an inevitable acquisition target. Packed with insights on capital allocation, market narratives, and tactical GTM strategy, this solo pod is a masterclass in navigating the new MedTech landscape.Episode BreakDown:00:00 – Cold Open: The Medtech Liquidity Problem Explained01:00 – Welcome Back & Why This Solo Episode Matters03:10 – Why VC Exits Have Slowed Dramatically05:20 – “Liquidity Design Problem” vs Funding Problem07:40 – What Is a Mini-Strategic? (Clear Definition)10:20 – Strategic Spin-Outs: GE Healthcare, DePuy, Solventum13:30 – Why Mini-Strategics Change the M&A Landscape16:00 – Dedicated Capital & Focused Governance Advantage18:30 – How Competition Gets Faster and Healthier20:40 – Expanding the Buyer Universe Beyond Big Strategics23:00 – Why Liquidity Drives Risk-Taking in Medtech25:30 – Venture Capital Concentration & Fewer Early Deals27:20 – Market Engineering: How Founders Create Leverage29:40 – The 5-Step Playbook to Build Acquirer Readiness31:30 – Social Media as a Market Testing Engine32:00 – Final Advice, Call to Action & OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to GrowMyMedtech.com to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfgSubscribe to our LinkedIn Newsletterhttps://www.stateofmedtechpodcast.com/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtechInstagram https://www.instagram.com/stateofmedtech/TikTok https://www.tiktok.com/@stateofmedtechX https://twitter.com/StateofMedTechFacebook https://www.facebook.com/stateofmedtech/Follow Omar M. Khateeb onLinkedIn https://www.linkedin.com/in/okhateeb/Instagram https://www.instagram.com/omar.m.khateeb/TikTok https://www.tiktok.com/@omarkhateebofficialX https://twitter.com/OmarMKhateebFacebook https://www.facebook.com/OmarMKhateeb/This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions#medtech #digitalhealth #medicaldevices #healthcareinnovation #healthtech
Embed this episode
NOW PLAYING
346:The 2026 MedTech Exit Playbook: How Spin-Outs Like DePuy Synthes Are Changing M&A Forever.
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.